Pre-Conference Programs • Nov. 8–9, 2022

Pre-Conference Programs


Tuesday, Nov. 8, 2022

*Times and program schedule subject to change.

Combination Therapy: Using Novel Approaches to Identify Novel Biomarkers, Inform Patient Selection, and Design Trials

2–5:45 p.m. EST*

The “Combination Therapy: Using Novel Approaches to Identify Novel Biomarkers, Inform Patient Selection, and Design Trials” program helps SITC to advance the science and application of cancer immunotherapy by bringing together high-level experts to provide perspective and big-picture ideas on key issues surrounding combination therapies and clinical trial design and to highlight the latest work in these areas. The program will explore the use of artificial intelligence, such as machine learning, to predict patient outcomes and identify novel biomarkers. Application of statistical models to refine and optimize clinical trial design and regulatory issues surrounding clinical trials of combination therapies will also be addressed. Armed with a deeper understanding of these challenges and considerations surrounding combination therapies, attendees will be equipped to develop therapies that are cost-efficient, faster, safer, and more effective for patients.

Learn More

Wednesday, Nov. 9, 2022

*Times and program schedule subject to change.

Primer on Tumor Immunology and Cancer Immunotherapy™

8 a.m.–5 p.m. EST*

The understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. The Primer on Tumor Immunology and Cancer Immunotherapy™ will also touch on emerging therapies and technologies to ensure attendees at all levels stay updated in our expanding field, while also laying a comprehensive foundational base for all SITC attendees.

Learn more


Combination Therapy: Applying Learnings from Past Successes and Failures to Future Treatments

9 a.m.–5:30 p.m. EST*

The Combination Therapy: Applying Learnings from Past Successes and Failures to Future Treatments helps SITC to advance the science and application of cancer immunotherapy by providing relevant and engaging content to basic, translational, and clinical researchers. This Workshop will explore how the underlying biology of combination therapies and how those combinations may change and overcome specific mechanisms of resistance. The Workshop also aims to discuss provocative questions concerning novel combination immunotherapeutic development armed with a deeper biological understanding of how rational combinations and sequences of therapies can overcome specific resistance mechanisms, attendees will be equipped to design effective clinical trials leading to better patient outcomes.

Learn more


Grant Writing Workshop

5:45–7:50 p.m. EST*

This program will feature two sessions. The first session opens with an overview of the grant submission process, briefly outlining funding opportunities outside the NIH and the principles of grant writing. This session also addresses big data along with NCI Officer Tips and Tricks in the grant writing process. The second session will consist of a “mock study section,” allowing attendees to experience how a study section evaluates a grant proposal. This will help attendees identify points that determine the success or failure of a grant proposal and help them optimize the process of grant re-submission. The session concludes with breakout question and answer sessions on various types of grants.

Learn more



PCP1.jpg
PCP1.jpg
PCP1.jpg